VIRGINIA ONEIL: Open Payments
NPI 1669471041 · NORWOOD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 28 payments from 17 companies in 2025. Trend: 2023 $1,051 · 2024 $748 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| 180 Medical, Inc. | 3 | $89 |
| Endo USA, Inc. | 3 | $88 |
| Astellas Pharma US Inc | 3 | $85 |
| ACCORD HEALTHCARE, INC. | 3 | $69 |
| Terumo Medical Corporation | 1 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Ferring Pharmaceuticals Inc. | 2 | $43 |
| Janssen Biotech, Inc. | 1 | $38 |
| Myriad Genetic Laboratories, Inc. | 2 | $30 |
| IMMUNITYBIO, INC. | 1 | $29 |
Products named: Veozah, Camcevi, AVEED, ANGIO-SEAL, GEMTESA, ADSTILADRIN, ERLEADA, PROLARIS.
Industry payments across MA — which companies pay providers there.
